About this trial
The goal of this study is the assess the use of remote monitoring of vital signs using commercially available medical devices in patients with advanced cancer admitted to a hospice inpatient unit for end-of-life care.
The objectives of the study are:
1. could remote monitoring of vital signs improve patient care through the earlier identification of infections and other (potentially reversible) problems; 2. could remote monitoring of vital signs improve the accuracy of our estimates about how long a person has to live; and c) determine the relationship between complaints of pain / other symptoms and vital signs.
Eligibility criteria
Qualifiers
Age ≥ 18 years old
Primary diagnosis of malignant disease
Admitted for end-of-life care (or focus of care changed to end-of-life care)
Estimated prognosis < 14 days
Disqualifiers
Primary diagnosis of non-malignant disease
Inability to provide informed consent
Contraindications to use of biosensor adhesive patch (e.g. chest wall skin problem, allergy to adhesive)
Trial design
Treatments tested in this trial
- Not listed